Mubariz Ahsan: Trends in Stroke Mortality in Peripheral Artery Disease from CDC WONDER Study
Mubariz Ahsan, Research Assistant at Rahmah Academy of Research Excellence, Co-Founder at OculaRIS, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Stroke, adding:
”Proud to share that our abstract has been published in Stroke, an American Heart Association journal, for the International Stroke Conference 2026.
Our study, titled ‘Trends and Disparities in Stroke-Related Mortality Among Adults with Peripheral Artery Disease in the United States: A CDC WONDER Analysis (1999–2023)’, explores long-term mortality trends and disparities in a high-risk population.
Grateful to my co-authors and mentors for their support, collaboration, and guidance throughout this work. This project was a valuable learning experience and a reminder of how meaningful clinical research can be when it focuses on real-world public health gaps.
Looking forward to continuing work that contributes to evidence-based medicine and better patient outcomes.”
Abstract WP077: Trends and Disparities in Stroke-Related Mortality Among Adults with Peripheral Artery Disease in the United States: A CDC WONDER Analysis (1999-2023)
Authors: Muhammad Ibrahim, Chaudhry Saad Sohail, Tooba Fida, Malik Aqeel Ahmad, Mubariz Ahsan, Muhammad Husnain Ahmad, Dheeraj Kumar, FNU Sahil, Sahil Jairamani, Hakim Wazir

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?
-
Nov 11, 2026, 15:12Perioperative Challenges in Hemophilia Patients on Rebalancing Therapies
-
Nov 11, 2026, 15:03Maria Elisa Mancuso: World-Renowned Faculty and 33 Global Participants Unite at Hemophilia Academy 2026
-
Nov 11, 2026, 15:01Hassan Raza: The JAK2 V617F Revolution
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian